AstraZeneca PLC Logo

AstraZeneca PLC

Global biopharma developing medicines for oncology, cardiovascular, respiratory & rare diseases.

AZN | IL

Overview

Corporate Details

ISIN(s):
GB0009895292 (+925 more)
LEI:
PY6ZZQWO2IZFZC3IOL08
Country:
United Kingdom
Address:
1 FRANCIS CRICK AVENUE, CB2 0AA CAMBRIDGE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

AstraZeneca PLC is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. The company's primary therapeutic areas include Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Rare Diseases. AstraZeneca develops, manufactures, and sells pharmaceutical and biotechnology products aimed at addressing complex health challenges for millions of patients worldwide. The firm maintains a significant research and development pipeline to create innovative treatments and transform healthcare through scientific advancement.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-01 16:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 9.2 KB
2025-09-29 08:30
Earnings Release
Enhertu improved IDFS in early BC in DB-05
English 35.9 KB
2025-09-29 08:04
Registration Form
Proposed new Articles of Association of AstraZeneca PLC
English 740.9 KB
2025-09-29 08:04
Registration Form
Existing Articles of Association of AstraZeneca PLC marked up to show proposed …
English 804.3 KB
2025-09-29 08:00
Pre-Annual General Meeting Information
AZN harmonises listing structure
English 16.3 KB
2025-09-29 07:58
Proxy Solicitation & Information Statement
Form of Proxy
English 144.8 KB
2025-09-29 07:53
Pre-Annual General Meeting Information
Circular and Notice of General Meeting
English 397.9 KB
2025-09-25 17:30
Director's Dealing
Director/PDMR Shareholding
English 21.4 KB
2025-09-22 08:05
Regulatory News Service
Koselugo recommended for EU approval
English 21.4 KB
2025-09-22 08:00
Regulatory News Service
Tezspire Recommended for Approval in EU for CRSwNP
English 33.6 KB
2025-09-17 08:05
Regulatory News Service
Saphnelo met primary endpoint in TULIP-SC
English 27.3 KB
2025-09-17 08:00
Regulatory News Service
Update on RESOLUTE Phase III trial
English 22.5 KB
2025-08-28 16:00
Major Shareholding Notification
Holding(s) in Company
English 8.2 KB
2025-08-26 16:00
Major Shareholding Notification
Holding(s) in Company
English 25.9 KB
2025-08-26 10:57
Major Shareholding Notification
Swedish 10.9 KB

Automate Your Workflow. Get a real-time feed of all AstraZeneca PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for AstraZeneca PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-11-13 Philip Broadley Other Buy 980 99,665.12 EUR
2024-03-08 Pascal Soriot Other Other 105,238 N/A
2024-03-05 Pascal Soriot Other Other 17,702 N/A
2024-03-04 Pascal Soriot Other Other 109,872 11,076,196.32 EUR
2024-03-04 Aradhana Sarin Other Other 59,125 5,960,391.25 EUR
2023-12-12 Anna Manz Other Buy 487 49,623.16 EUR
2023-11-22 Michel Demare Other Buy 1,000 101,700.00 EUR
2023-11-21 Michel Demare Other Buy 1,000 101,052.24 EUR
2023-04-28 Michel Demare Other Buy 2,000 234,020.00 EUR
2023-03-23 Pascal Soriot Other Other 138,093 N/A

Peer Companies

Company Country Ticker View
WAKAMOTO PHARMACEUTICAL CO.,LTD. Logo
Develops gastrointestinal and ophthalmic drugs for the health challenges of an aging society.
Japan 4512
WELLBIOTEC CO.,LTD Logo
Diversified in biopharma, EV chargers, and lithium supply for batteries.
South Korea 010600
WHANIN PHARM CO.,LTD Logo
Develops and sells pharmaceuticals, specializing in CNS, cardiovascular, and GI drugs.
South Korea 016580
WooGeneB&GCO.,Ltd Logo
Manufactures veterinary medicines, vaccines, and supplements for livestock and aquatic animals.
South Korea 018620
Xbrane Biopharma Logo
Develops affordable biosimilars for serious diseases using patented, high-yield production tech.
Sweden XBRANE
Xintela AB Logo
Develops stem cell therapies for osteoarthritis and venous leg ulcers using proprietary technology.
Sweden XINT
Xspray Pharma Logo
Develops improved cancer drugs (PKIs) using patented tech to circumvent secondary patents.
Sweden XSPRAY
Y.B Urban Renewal - Residential Development LTD Logo Israel CSURE-M
YUHAN CORPORATION Logo
A pharmaceutical & chemical firm developing drugs, supplements, consumer products, and APIs.
South Korea 000100
YUKI GOSEI KOGYO CO.,LTD. Logo
Manufactures fine chemicals, amino acids, and APIs via organic synthesis for global industries.
Japan 4531

Talk to a Data Expert

Have a question? We'll get back to you promptly.